Andrejs Leimanis

2k citations
5 papers · 1.7k · 1 hit paper · h-index 3

Impact in

Papers in

Andrejs Leimanis

5 papers receiving 1.7k citations

Andrejs Leimanis's Hit Papers

The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months 2006 · 1.6k citations
1.6k0+6+13Years since publication5001k1.5k

Peers

Andrejs Leimanis
Comparison fields: 5 of 79
  • Geriatrics and Gerontology 215
  • Family Practice 53
  • Psychiatry and Mental health 194
  • Toxicology 39
  • Internal Medicine 20
Replace Emmae N. Ramsay with:
Emmae N. Ramsay Australia
Ida Fortino Italy
Melisa J. Litchfield Australia
Géric Maura France
Machelle Wilchesky Canada
Øystein Karlstad Norway
Hans Petri Netherlands
Nada Khan United Kingdom
Lars Age Johansson Sweden
Andrew Maguire Spain
Andrejs Leimanis relative to Emmae N. Ramsay Australia Emmae N. Ramsay's profile →
Citations per field
00.5×1.5×2×2.5×
Emmae N. Ramsay · 1×
Citations per year

Countries citing papers authored by Andrejs Leimanis

Since Specialization
Citations

This map shows the geographic impact of Andrejs Leimanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrejs Leimanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrejs Leimanis more than expected).

Fields of papers citing papers by Andrejs Leimanis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrejs Leimanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrejs Leimanis. The network helps show where Andrejs Leimanis may publish in the future.

Co-authors

The 21 scholars most cited alongside Andrejs Leimanis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrejs Leimanis Line = papers co-authored together Andrejs Leimanis links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
Hit paper breakdown →
20061580
2 200791
3 200922
4
[Low quality of drug use among the elderly. An analysis based on the national drug registry shows regional differences].
20073
5
[Epidemiologic surveillance of myocardial infarction shows fewer cases but large regional differences].
19911

About Andrejs Leimanis

Andrejs Leimanis is a scholar working on Geriatrics and Gerontology, Family Practice, Cardiology and Cardiovascular Medicine, Health Information Management and Economics and Econometrics, having authored 5 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (3 papers), Pharmaceutical Economics and Policy (1 paper), Medical Coding and Health Information (1 paper), Blood Pressure and Hypertension Studies (1 paper), Medication Adherence and Compliance (1 paper), Acute Myocardial Infarction Research (1 paper) and Healthcare Systems and Public Health (1 paper). The work is most often cited by research in Geriatrics and Gerontology (215 citations), Family Practice (53 citations), Psychiatry and Mental health (194 citations), Toxicology (39 citations) and Internal Medicine (20 citations). Andrejs Leimanis has collaborated with scholars based in Sweden, Italy and Netherlands. Frequent co-authors include Måns Rosén, Björn Wettermark, B Westerholm, Niklas Hammar, Ulf Bergman, Ingemar R. Persson, Anders Sundström, Petra Otterblad Olausson, Kristina Johnell and Johan Fastbom. Their work appears in journals such as Journal of Hypertension, Pharmacoepidemiology and Drug Safety, Annals of Pharmacotherapy and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact